Rishon-LeZion, Israel

Gary Gellerman

This inventor holds 3 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Ariel-University Research and Development Company Ltd., Ariel Scientific Innovations Ltd.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Gellerman. Retrieved from https://idiyas.com/inventor/gary-gellerman-4zxjxqgw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gary Gellerman - Pioneering Innovator in Drug Delivery Systems

Introduction

Gary Gellerman, an accomplished inventor based in Rishon-LeZion, Israel, has made significant contributions to the field of drug delivery systems. With three patents to his name, Gellerman's innovative work focuses on improving the efficacy of pharmaceutical treatments, particularly in cancer therapy.

Latest Patents

Gellerman's latest patents showcase his commitment to advancing medical science. His first notable patent is a peptide-based multiple-drug delivery vehicle. This invention presents a unique molecular structure that consists of a targeting moiety, a multifunctional peptide platform, and a variety of controllably released bioactive agents. This innovative approach aims to enhance the precision and effectiveness of drug delivery.

Another significant patent by Gellerman involves anticancer drug conjugates. This invention includes a conjugate composed of two residues of structurally and/or mechanistically different anticancer bioactive agents. These are coupled through a biocleavable linking moiety, offering a novel method for treating cancer and creating pharmaceutical compositions that can potentially transform cancer therapies.

Career Highlights

Throughout his career, Gary Gellerman has contributed his expertise to several organizations, including Ariel University Research and Development Company Ltd. and Ariel Scientific Innovations Ltd. His work in these institutions has not only advanced his research but also enriched the academic and practical landscapes of pharmaceutical sciences.

Collaborations

Gellerman has collaborated with prominent colleagues such as Yosi Gilad and Helena Tuchinsky. These collaborations have fostered a stimulating environment for innovation, allowing the combination of diverse expertise and ideas, further driving the progress of drug delivery systems.

Conclusion

Gary Gellerman stands out as a pioneering figure in the field of drug delivery innovation. With a focus on creating more effective treatment methods for patients, his contributions are bound to leave a lasting impact on the medical and pharmaceutical industries. As his work continues to evolve, Gellerman remains a key inventor to watch in the realm of innovative therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…